Universal Ibogaine Inc.
IBO.V
TSX
01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
---|---|---|---|---|---|
Net Income | -1.66M | -1.61M | -1.51M | -1.15M | -878.60K |
Total Depreciation and Amortization | 252.00K | 249.90K | 252.70K | 247.50K | 241.60K |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 789.90K | 800.60K | 805.10K | 391.00K | 148.50K |
Change in Net Operating Assets | -137.40K | -104.20K | -167.90K | -35.00K | 179.40K |
Cash from Operations | -753.30K | -661.90K | -617.60K | -551.30K | -309.00K |
Capital Expenditure | -29.30K | -36.10K | -57.70K | -56.10K | -73.50K |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -29.30K | -36.10K | -57.70K | -56.10K | -73.50K |
Total Debt Issued | -- | -- | -- | 0.00 | 380.00K |
Total Debt Repaid | -218.70K | -219.00K | -225.30K | -131.90K | -103.30K |
Issuance of Common Stock | 1.21M | 1.53M | 1.63M | 1.41M | 417.20K |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -10.90K | -429.90K | -429.90K | -337.20K | -3.20K |
Cash from Financing | 711.90K | 650.50K | 719.30K | 694.10K | 510.30K |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -70.80K | -47.50K | 44.00K | 86.70K | 127.80K |